REQUEST A DEMO
Total
USD $0.00
Search more companies

Be Vaccines Pte. Ltd. (Singapore)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Be Vaccines Pte. Ltd. Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Be Vaccines Pte. Ltd. is a company in Singapore, with a head office in Singapore. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on February 28, 2013. 50 (estimated) employees currently work for Be Vaccines Pte. Ltd.. From the latest financial highlights, Be Vaccines Pte. Ltd. reported a net sales revenue increase of 85.59% in 2023. Its’ total assets recorded a growth of 11.35%. The net profit margin of Be Vaccines Pte. Ltd. decreased by 1.41% in 2023.

Headquarters
4 Battery Road, #25-01 Bank Of China Building, Singapore
Singapore; Singapore; Postal Code: 049908

Contact Details: Purchase the Be Vaccines Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Be Vaccines Pte. Ltd. report to view the information.
Outstanding Shares:
Purchase the Be Vaccines Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Be Vaccines Pte. Ltd. report to view the information.
Incorporation Date:
February 28, 2013
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Be Vaccines Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
85.59%
Total operating revenue
85.59%
Net Profit (Loss) for the Period
53.54%
Total assets
11.35%
Total equity
13.84%
Net Profit Margin
-1.41%
Return on Equity (ROE)
3.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?